243 filings
Page 2 of 13
424B5
g0oushn hh
11 Apr 24
Prospectus supplement for primary offering
1:30pm
424B5
erqm9oi3v
9 Apr 24
Prospectus supplement for primary offering
9:15am
8-K
a6a7774 kg9z
5 Apr 24
Allarity Therapeutics Announces 1-for-20 Reverse Stock Split
8:30am
8-K
11hfx ywrxe9
4 Apr 24
Material Modifications to Rights of Security Holders
5:01pm
8-K
ydgl2u
1 Apr 24
Regulation FD Disclosure
9:36am
8-K
hnocmasp
26 Mar 24
Regulation FD Disclosure
8:05am
S-8
9sk0 ceav90a5rs4uutc
25 Mar 24
Registration of securities for employees
4:33pm
8-K
63dbeoj
19 Mar 24
Entry into a Material Definitive Agreement
8:41pm
424B5
786go6up1
19 Mar 24
Prospectus supplement for primary offering
8:40pm
8-K
eel12dyd8xv
15 Mar 24
Entry into a Material Definitive Agreement
9:14am
8-K
x1zehxg brw
8 Mar 24
Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update
8:38am
8-K
lz5h9ku8xbt1r kf0ut
4 Mar 24
Departure of Directors or Certain Officers
4:05pm
8-K
piaiz5 ze6ar54
1 Mar 24
Entry into a Material Definitive Agreement
9:21am
PRER14A
tfgnlu5tdwwe2bn
23 Feb 24
Preliminary revised proxy
4:09pm
8-K
iqm3vexeqayi8m ep4vn
14 Feb 24
Entry into a Material Definitive Agreement
9:03am
D
mypos
2 Feb 24
$1.40 mm in debt, sold $400.00 k, 1 investor
5:03pm
8-K
kuvu034
1 Feb 24
Termination of a Material Definitive Agreement
4:40pm